Search Results - "Larrey D"

Hepatic Effects, Potential Drug-Induced Liver Injury, and Other Liver Safety Considerations of Chimeric Antigen Receptor T-Cell (CAR-T) Therapy in the New Era of Expanding Non-oncology Indications: Literature Review and Expert Consensus.

Authors: Fettiplace A Regev A Kiazand A et al.

Source: Drug safety [Drug Saf] 2026 Jun; Vol. 49 (6), pp. 631-654. Date of Electronic Publication: 2025 Dec 04.

Publication Type: Consensus Statement; Journal Article; Review

Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9002928 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1942 (Electronic) Linking ISSN: 01145916 NLM ISO Abbreviation: Drug Saf Subsets: MEDLINE

Author Index.

Source: Fundamental & Clinical Pharmacology. Jun2024 Supplement 1, Vol. 38, p213-226. 14p.

Liver Safety of the Dual Neurokinin-1/-3 Receptor Antagonist Elinzanetant.

Authors: Lewis JH Andrade RJ Larrey D et al.

Source: Drug safety [Drug Saf] 2026 Aug; Vol. 49 (8), pp. 985-1002. Date of Electronic Publication: 2026 Mar 18.

Publication Type: Journal Article; Review

Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9002928 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1942 (Electronic) Linking ISSN: 01145916 NLM ISO Abbreviation: Drug Saf Subsets: MEDLINE

Persistent Cholestatic Hepatitis after Choledocholithiasis Removal: A Rare Case of Vanishing Bile Duct Syndrome.

Authors: Leonard, Graham Sulaiman, Raed A. Xie, Chencheng

Source: Case Reports in Gastroenterology. Mar2026, Vol. 20 Issue 1, p126-131. 6p. 1 Illustration.

From Supplements to Therapeutics: Repurposing Antioxidant Compounds in the Management of NAFLD (Non-Alcoholic Fatty Liver Disease).

Authors: Theodorou, Rafailia-Eirini Vrettos, Nikiforos Theodosis-Nobelos, Panagiotis

Source: Applied Sciences (2076-3417); May2026, Vol. 16 Issue 9, p4239, 33p

From Discovery to Cure—Where Are We Now? Mortality Trends in Chronic Hepatitis C: An Analysis of CDC WONDER Database (1999–2023).

Authors: Ullah, Ashraf Wazir, Hina Sultany, Abdullah et al.

Source: Viruses (1999-4915). May2026, Vol. 18 Issue 5, p576. 11p.

Bioactivation and reactivity research advances – 2023 year in review.

Authors: Wang, Shuai Argikar, Upendra A. Chatzopoulou, Maria et al.

Source: Drug Metabolism Reviews. Aug2024, Vol. 56 Issue 3, p247-284. 38p.

Short communication: miRNA122 interrogation via PCR-Free method to track liver recovery.

Authors: Marín-Romero, Antonio Di Zeo-Sánchez, Daniel E. Tabraue-Chávez, Mavys et al.

Source: PLoS ONE. 5/30/2025, Vol. 20 Issue 5, p1-10. 10p.

Mitigating Severe Ribociclib‐Hepatotoxicity With Corticosteroids.

Authors: Williamson, Julie Pletneva, Maria Kim, Rebecca G. et al.

Source: Case Reports in Oncological Medicine. 4/24/2026, Vol. 2026, p1-4. 4p.

Risk of Liver and Non-Liver Malignancy in HCV-Infected Patients with Cirrhosis After Direct-Acting Antiviral Treatment.

Authors: Zarębska-Michaluk, Dorota Dobrowolska, Krystyna Flisiak, Robert et al.

Source: Cancers. Jul2026, Vol. 18 Issue 13, p2079. 17p.

Hepatic adverse effects of valproic acid: Management strategies.

Authors: Bouaziz, Imen Atheymen, Rim Sahnoun, Rym et al.

Source: Indian Journal of Pharmacology. May/Jun2026, Vol. 58 Issue 3, p266-271. 6p.

Author index.

Source: Fundamental & Clinical Pharmacology. Apr2012 Supplement, Vol. 26, p123-137. 15p.

Author Index.

Source: Fundamental & Clinical Pharmacology. Jun2018 Supplement S1, Vol. 32, p100-110. 11p.

Author Index.

Source: Basic & Clinical Pharmacology & Toxicology. Jun2011 Supplement 1, Vol. 109, p165-176. 12p.

Author Index.

Source: Clinical Microbiology & Infection. Volume 17, Issue Supplement S4, Vol. 17 Issue S4, pS835-S895. 61p.

Randomized Controlled Trial Evidence on Peroxisome Proliferator‐Activated Receptor (PPAR) Agonists in Primary Biliary Cholangitis: A Systematic Review and Meta‐Analysis.

Authors: Dar, Marrium Sultan Fatima, Tooba Azhar, Syeda Dua et al.

Source: International Journal of Hepatology. 12/2/2025, Vol. 2025, p1-10. 10p.

Author index.

Source: Journal of Viral Hepatitis. Nov2003, Vol. 10 Issue 6, p471. 5p.

Clinical Characteristics and Predictive Factors of Immune-Mediated Cholangitis: A Large Single-Center Retrospective Observational Study.

Authors: Iijima, Noriaki Ishii, Yasutaka Nakamura, Shinya et al.

Source: Cancers. Feb2026, Vol. 18 Issue 4, p685. 19p.

Expert consensus on optimal management of liver-related adverse events during CDK4/6 inhibitor therapy.

Authors: Pernas S Forns X Martínez-Sáez O et al.

Source: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2026 May 10. Date of Electronic Publication: 2026 May 10.

Publication Type: Journal Article; Review

Journal Info: Publisher: Springer Italia Country of Publication: Italy NLM ID: 101247119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1699-3055 (Electronic) Linking ISSN: 1699048X NLM ISO Abbreviation: Clin Transl Oncol Subsets: MEDLINE

Waterloo.

Authors: Goddard, Jonathan Charles¹

Source: BJU International. Jun2015 Supplement, Vol. 115, p2-5. 4p.